Business Standard

Alkem Labs dips 11% as USFDA issues 13 observations for Daman facility

The stock dipped 11% to Rs 1,858 on the BSE in intra-day trade on back of heavy volumes.


SI Reporter Mumbai
Shares of Alkem Laboratories have dipped 11% to Rs 1,858 per share on the BSE in intra-day trade after the company said it has received a Form 483 with 13 observations from the US Food & Drug Administration (FDA) for its manufacturing facility at Amaliya, Daman.

“The US FDA had conducted an inspection at the Company's manufacturing facility located at Amaliya, Daman, India from 19th March, 2018 to 27th March, 2018. Post the inspection, the Company has received a Form 483 with thirteen observations,” Alkem Labs said in a regulatory filing.

The company shall put together a detailed

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Mar 28 2018 | 1:39 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to